RightFit
RecruitingPhase not listed

Understanding Chronic Lymphocytic Leukemia

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects tissue samples and medical information to learn what causes chronic lymphocytic leukemia (CLL) and how it works. CLL is a type of blood cancer. The study is for new and current patients with CLL or certain other conditions that affect white blood cells.

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • New or current patients seen for treatment of monoclonal B-cell lymphocytosis, which means having extra B cells, a type of white blood cell.
  • Patients with any low-grade lymphoproliferative disorder, a slow-growing condition in which the body makes too many of certain white blood cells.
  • Patients with CLL seen at the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere.

Who can't join

    Simplified for readability. The official criteria below are what the study team uses.

    Official eligibility criteria

    Inclusion Criteria: * New and existing patients seen for treatment of monoclonal B-cell lymphocytosis * Any low grade lymphoproliferative disorder * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere Exclusion Criteria: \-

    Study sites (1)

    MA